Abstract
Purpose
We aimed to systematically review recent publications (01/2014–03/2017) with longitudinal designs allowing for the assessment of the prospective risk of insomnia on new onset mental illness in key conditions: anxiety, depression, bipolar disorder, posttraumatic stress disorder, substance use disorders, and suicide.
Recent Findings
A literature yielded 1859 unique articles meeting search criteria were identified; 16 articles met all selection criteria and reviewed with some studies reporting on more than one mental health outcome. Overall, the review supports the hypothesis that insomnia is a predictor of subsequent mental illness.
Summary
The evidence is strongest for an insomnia-depression relationship. The new studies identified and reviewed add to a modest number of publications supporting a prospective role of insomnia in new onset mental illness in three areas: anxiety disorders, bipolar disorder, and suicide. The few selected new studies focused on SUD were mixed, and no studies focused on PTSD were identified that met the selection criteria. Treatment of insomnia may also be a preventive mental health strategy.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Insomnia has a somewhat unique history in the annals of mental health. Unlike many disorders, insomnia was long conceptualized as simply a symptom associated with other, primary mental health disorders [1]. As such, insomnia was seldom a treatment target when it presented with another psychiatric condition. Instead, the general treatment approach was to address the underlying disorder with the assumption that sleep difficulties would resolve as an associated symptom (e.g., treating depression would alleviate insomnia).
Two seminal studies began the slow dismantling of these assumptions by establishing that the presence of insomnia was a prospective risk factor for the development of psychiatric illness [2, 3]. Ford and Kamerow utilized data from the National Institute of Mental Health Epidemiologic Catchment Area study [4] to assess whether the presence of baseline insomnia contributed to a higher incidence of a psychiatric disorder 1 year later [2]. Individuals with baseline insomnia that remitted at 1 year, compared to those with no baseline insomnia, were at higher risk of an incident psychiatric disorder at the 1 year follow-up with an adjusted odds ratio (AOR) of 2.4 and a 95% confidence interval (CI) of 1.2–4.8. Individuals with insomnia present at both time points were at higher risk (AOR = 5.6; CI: 1.1–26.9). Similar findings were observed by Breslau et al. among 979 young adults assessed at baseline and 3 years later [3]. For example, baseline insomnia was associated with increased risk for incident major depression (AOR = 3.95; 2.22–7.00), anxiety disorder (1.97; 1.08–3.60), and drug use disorder (7.18; 2.13–24.37), but not alcohol use disorder (1.72; 0.85–3.52).
Subsequent work has both corroborated and extended these early findings. In one domain, depression, the literature has been large enough to conduct a meta-analysis. Baglioni and colleague’s 2011 meta-analysis included 21 longitudinal studies, published between 1980 and 2010 that examined insomnia’s relationship with the development of depression [5]. Their analyses revealed that insomnia doubled the odds of developing depression. In addition to this type of work, two other bodies of work have helped to transform the perception of insomnia as a symptom to insomnia as a disorder [6]. One is literature demonstrating that insomnia co-occurring with other psychiatric conditions responds well to insomnia treatments with some gains generalizing to non-sleep symptoms [7,8,9]. The other is literature underscoring that when insomnia is not treated in the course of treating other psychiatric illness, it can blunt overall treatment response and/or remains a residual problem (e.g., [10, 11]). As segments of the health care field continue to shift toward an appreciation of the importance of treating insomnia, studies testing the hypothesis that insomnia precipitates new onset mental illness can further inform the views of individual clinicians and systems of care.
Contributing to the ongoing re-appreciation of the importance of insomnia in clinical care is, in part, the impetus for the current systematic review. In addition, we wished to determine the extent to which new literature now exists to expand upon Bagloni and colleagues’ depression focus [5], allowing for the examination of whether insomnia is a precursor to other mental health disorders. Focusing on studies that were longitudinal in nature, the systematic review that follows aims to synthesize the literature published during the past 3 years (2014–2017). The review covers insomnia’s association with new onset mental illness including anxiety, depression, bipolar disorder, posttraumatic stress disorder (PTSD), substance use disorders (SUDs), and suicide.
Method
Adhering to the PRISMA guidelines [12], a systematic review was conducted examining the most recent literature related to insomnia’s role as a precipitant to new onset mental illness. PubMed and PsycINFO databases were searched for a period beginning January 1, 2014 and ending March 14, 2017. Boolean search logic was utilized to identify all articles with content inclusive of insomnia with the following search terms: depress*, MDD, suicid*, anxiety, GAD, PTSD, post traumatic stress, posttraumatic stress, acute stress, bipolar, manic depress*, alcohol, AUD, SUD, substance*, using “NOT” to separate keywords in subsequent searches (e.g., insomnia AND anxiety NOT depress*).
The following eligibility criteria were used to select articles: (1) the manuscript was available in the English language, (2) the study utilized human subjects, (3) the study consisted of original research, (4) the manuscript was published in a peer-reviewed outlet, (5) the manuscript reported data on the association between insomnia and the outcome of interest (i.e., new onset of depression, anxiety, PTSD, SUD, bipolar, or suicidality), and (6) the study utilized longitudinal design.
Once studies were identified from the literature search, the review occurred in a three-step process. First, titles and keywords were reviewed to confirm that the publication was focused on insomnia and at least one of the mental health conditions of interest. Second, a review of abstracts was undertaken to confirm that insomnia was an independent variable of interest and that the study design was longitudinal. Third, a full text review was completed to identify articles meeting all selection criteria.
Results
As depicted in Fig. 1, our literature yielded 1859 unique articles after accounting for duplicates. Initial review resulted in the identification of 120 articles that underwent full text review. Among these, 16 articles (see Table 1) were included in the review that met all inclusion criteria including the assessment of insomnia as a precursor to anxiety (n = 5), bipolar disorder (n = 2), depression (n = 11), alcohol/substance use disorders (n = 3), and suicide (n = 2). The sum does not add to 16 as several studies had more than one mental health outcome [13, 14, 15•, 17, 18•].
Insomnia and Anxiety
Insomnia is highly prevalent among patients with a variety of anxiety disorders and is a diagnostic feature of separation anxiety disorder and generalized anxiety disorder (GAD). In early epidemiologic studies, the presence of insomnia was associated with increased risk for the development of a subsequent anxiety disorder 1–3 years later [2, 3].
Five (5) new studies were identified that addressed the role of insomnia in the development of an anxiety disorder [13, 14, 15•, 16, 17]. In a retrospective cohort study of over 30,000 individuals in Taiwan, patients with insomnia alone, compared to those with no insomnia diagnosis and no use of sedative-hypnotic medications, had a significantly higher incidence of an anxiety disorder over a 6-year period (adjusted hazard ratio (AHR) = 2.38 (95% CI 2.21–2.57) [15•]. The AHR was more pronounced among insomnia patients who were also prescribed hypnotic medications (AHR = 6.55: 95% CI 6.06–7.08). In a community sample of older adults (N = 909), baseline insomnia was associated with increased risk for developing incident anxiety symptoms and an incident anxiety disorder 2 years later [16]. Notably, insomnia was one of only two demographic, socioeconomic, and clinical factors associated with incident anxiety. In a sample of Norwegian shift-workers (N = 799) assessed in waves 2 years apart, a bidirectional relationship was observed wherein anxiety was associated with subsequent insomnia and insomnia was associated with subsequent anxiety [17]. In two smaller studies, focused on adolescents, baseline insomnia did not predict subsequent obsessive compulsive disorder (OCD) or social phobia 6 months later [13], but persistent childhood insomnia was associated with anxiety at 18 years of age in a separate study [14]. In sum, these new studies offer continued support for the contribution of insomnia in the development of anxiety disorders.
Some possibilities exist to explain an insomnia-anxiety relationship. For instance, hyperarousal has long been considered an etiologic factor in the development of insomnia [29, 30] and may represent a shared pathway by which both insomnia and anxiety conditions may develop. It is conceivable that when insomnia develops, first, it creates the conditions for anxiety-vulnerable individuals to develop a full anxiety disorder. In a classic study using caffeine, Bonnet and Arand induced objective and subjective insomnia in a sample of good sleepers who reported a number of symptoms associated with hyperarousal and psychological distress including increased anxiety [31]. This study suggests that acute insomnia leads to the manifestation of acute anxiety symptoms. The mechanisms for the contribution of insomnia to the development of a specific phobia or to OCD are somewhat more speculative. Nonetheless, the chronic experience of insomnia not only contributes to hyperarousal but to impaired emotion regulation [32, 33]. Together, or in concert, this could expose vulnerabilities for those at risk for developing these specific anxiety disorders. GAD presents a more interesting case study. Here, one can envision that insomnia leads to excessive worry about not only sleep and the consequences of poor sleep but to more generalized worry that meets diagnostic criteria for GAD. Indirect evidence for a prospective insomnia-anxiety relationship can be gleaned from clinical trials. For instance, a meta-analysis of cognitive-behavior therapy for insomnia (CBT-i) trials found a moderate effect of the intervention on concomitant anxiety (d = 0.41; 95% CI [0.32–0.49]) among 72 trials reviewed [34]. One small, but novel, trial randomized participants with co-occurring GAD and insomnia to receive GAD followed by insomnia treatment, or vice-versa [35]. In this trial, although superior benefits in both anxiety and sleep were achieved by initiating treatment for GAD first, insomnia treatment did improve worry symptoms. Overall, further work is needed to ascertain how insomnia confers added risk in the development of anxiety disorders.
Insomnia and Bipolar Disorder
Sleep disturbance is common among patients with bipolar disorder both during and between episodes [36] and often consists of symptoms of insomnia [37]. There is also some evidence that short sleep times are prospectively associated with both manic and depressive symptoms in patients with bipolar disorder [38]. Both clinical and experimental data support sleep disturbance (typically in the form of insomnia-like sleep disturbance, but at times in the form of hypersomnolence) as a prodrome for relapse in bipolar disorder [39]. In general, insomnia or diminished sleep needs are generally considered to be precursors to (and symptoms of) manic episodes as well as contributors to bipolar disorder. This relationship, however, is based on a relatively small literature and is complicated by the prevalence of hypersomnia in some bipolar patients during depressive episodes.
In the current review, only two new studies were identified that addressed the role of insomnia in the development of bipolar disorder [15•, 18•]. In the Taiwanese retrospective cohort study of Chung et al., insomnia alone, compared to no insomnia diagnosis and no hypnotic medications, was associated with a significantly higher incidence of an anxiety disorder over a 6-year period (AHR = 2.14; [1.48–2.88]) [15•]. As with anxiety disorders as the outcome, the hazard ratio for bipolar disorder was more pronounced among insomnia patients who were also prescribed hypnotics (AHR = 14.69; [11.11–19.43]). In a separate 10-year longitudinal study of adolescents and adults aged 14–24 in Munich, Germany, baseline insomnia predicted incident bipolar disorder (AOR = 1.41; [1.11–1.79]) [18•]. In adjusted models using single sleep items instead of a summed insomnia variable, trouble falling asleep and early morning awakening were each individually predictive of bipolar disorder, whereas restless/disturbed sleep was not.
These two epidemiologic studies are a significant addition to the literature, supporting the role of insomnia in the subsequent development of bipolar disorder. Indirect support for this relationship is also available from what may be the only controlled clinical trial of insomnia treatment in bipolar patients [40]. In this small clinical trial (N = 58), CBT-i adapted for bipolar disorder was associated with lower relapse rates to manic and depressive episodes compared to psychoeducation over a 6-month follow-up period. Finally, besides there being a genetic vulnerability for bipolar disorder, which becomes exposed and activated by insomnia, the most often-mentioned mechanistic candidates for how insomnia may be causally related to bipolar disorder are via alterations in circadian rhythms and alterations in emotion regulation [18•, 32, 33].
Insomnia and Depression
As noted in the introduction, the prospective relationship of insomnia to the development of depression was the focus of a large meta-analysis published in 2011, which found insomnia to significantly increase the risk of a new depressive episode [5]. Eleven new studies that addressed the role of insomnia in the development of depression, published during our search window, were identified [13, 14, 15•, 17, 18•, 19,20,21,22,23, 24•]. Of four studies among children or adolescents, two supported a relationship of insomnia to subsequent depression [13, 18•], one found no such association [14], and the fourth found mixed support across eight waves of data collection over a 10-year period [23].
Among the studies conducted with adult samples, four supported a relationship between insomnia and subsequent depression [15•, 20, 22, 24•], while one of the studies did not [17], and two had mixed or inconclusive findings [19, 21]. In one study with mixed findings, 2088 women had insomnia and depression in week 32 of pregnancy and week 8 postpartum [19]. Prenatal insomnia was associated with postpartum depression in univariate but not adjusted analyses. In addition, women with new onset postpartum depression had higher prenatal levels of insomnia severity than those women with no pre- or postpartum depression. Similarly, in a small sample (N = 54) comparing good sleepers to those with acute insomnia at a baseline evaluation, mean depression scores 3 months later were higher (p < .05) among those with insomnia, but the sample was too small to test for the significance of five incident cases of depression in the acute insomnia group compared to one such case in the good sleeper group [21].
Among studies with more consistently positive findings, the Chung et al. retrospective cohort study reported that incident depression disorder was associated with baseline insomnia both with (AHR = 11.86; [10.58–13.29]) and without (2.74; [2.41–3.12]) hypnotic medications [15•]. In one study of 1137 participants with no baseline depression, insomnia was associated with incident depression over an average of 7.5 years (AOR = 1.85; [1.06–3.23]) [22] and insomnia severity was the only baseline predictor of major depressive episodes over an 18-month period in another study [24•]. In a unique study that assessed stress reactivity at baseline, insomnia 1 year later, and depression an additional year later, insomnia was associated with an increased risk for depression (OR = 3.17; p < .01) and mediated the relationship between stress reactivity and depression [20].
Overall, then, these studies provide support for the prospective contribution of insomnia in the development of depression, further solidifying a relatively large literature base that predated the current review. Indirect evidence for this prospective relationship is also available from clinical trials in depressed samples. For example, CBT-i significantly reduced depressive symptoms in a large randomized trial (N = 1149) up to 6 months following treatment [41] and to enhanced depression remission rates of antidepressant treatment (61 compared to 33% with antidepressant alone) [42].
As detailed more explicitly elsewhere, a parallel process model of insomnia and depression proposes that alterations in the neurobiologic and cognitive-behavioral domains interact in the pathogenesis of co-occurring insomnia and depression [43]. In the neurobiologic domain, for instance, insomnia and depression are each characterized by similar changes in stress hormone secretion and elevated levels of inflammatory cytokines, which are each implicated in the etiology and exacerbation of depressive symptoms [44,45,46,47]. From a cognitive-behavioral perspective, emotional and cognitive consequences of insomnia may lead to a sense of loss of control that contribute to and activate other depressive schema such as hopelessness. In addition, the capacity to cope with or manage normal life stressors may be weakened as a result of chronic insomnia, which may amplify the negative or depressogenic valence of these life events [43].
Insomnia and PTSD
Sleep disturbance in general has long been recognized as a “hallmark” feature of PTSD [48]. Insomnia is especially pronounced among individuals with PTSD. Prospective data that speak to the role of insomnia in the development of PTSD support such a relationship but is somewhat limited [49]. We actually found no new prospective studies meeting our selection criteria.
There are two new studies, however, which do support an association between the presence of insomnia and the maintenance of PTSD [50, 51]. In addition, as reviewed by others, there are indications that treating insomnia in the context of PTSD can ameliorate non-sleep PTSD symptoms [49, 52]. In fact, a meta-analysis comprised of 11 clinical trials investigating the delivery of cognitive-behavioral sleep interventions in participants with PTSD revealed a moderate effect size for reductions in PTSD severity (d = 0.58) [53].
Overall, however, there remains the need for studies to assess whether the presence of insomnia increases the risk for the development of PTSD among individuals exposed to traumatic experiences. Some potential mechanisms for this to occur have been nicely reviewed by Germain [52]. Our view is that there is far more evidence for the role of insomnia to perpetuate and maintain PTSD than there is for insomnia to be a causal factor in the development of PTSD. This, of course, is an important empirical question to be tested
Insomnia and SUD
As in other mental health conditions reviewed, sleep disturbance often in the form of insomnia is highly prevalent among individuals with alcohol use disorder (AUD) and SUD [54]. Sleep problems in early childhood have previously been shown to prospectively predict substance-related problems in adolescence [55] with similar prospective observations among young adults [3]. Three new studies were identified that addressed the role of insomnia in the development of substance use disorders [15•, 25, 26].
In a study of adolescents that included those with and without a past or current AUD, for those with no baseline AUD (N = 349), insomnia predicted AUD symptoms 1 year later [25]. This association did remain significant at 3- and 5-year follow-ups. Instead, at these latter time points, baseline sleep variability was prospectively associated with AUD symptoms. Interestingly, unlike insomnia and sleep variability, baseline depression was not a predictor at any time point in adjusted models. Another longitudinal study assessed adolescents (N = 6504) at baseline and at 1- and 6-year follow-ups [26]. Baseline trouble falling or staying asleep predicted only 1 year interpersonal problems and illicit drug use, but not other SUD symptoms such as binge drinking, driving while drunk, or drug-related problems in fully adjusted models. Trouble sleeping at the 1-year follow-up predicted interpersonal problems, driving while drunk, drug-related problems, and illicit drug use at the 6-year follow-up. In addition to these mixed findings, lower total sleep time, which was also included in the models, also predicted SUD symptoms. It is unknown, of course, whether a variable that more robustly captured the presence or severity of insomnia disorder would have strengthened or weakened findings. In contrast, the Chung et al. study, which used medical record diagnostic coding as variables, reported that incident substance-related disorder was associated with baseline insomnia with (AHR = 4.12; [3.45–4.93]) and without (1.91; [1.61–2.26]) hypnotic medications over a 6-year follow-up period (15).
The addition of these new studies provides modest support for the role of insomnia in the development of new onset AUD/SUDs. Overall, the evidence does not overwhelmingly support this association. This is another area where more data is needed to ascertain the prospective risk for AUD/SUDs posed by insomnia. While not the focus of this review, the same can be said for the literature as it relates to whether insomnia increases the risk for relapse following AUD/SUD treatment where a relatively small body of both prior and newer work support the presence of this relationship (see, for example, [56, 57]).
Most proposed insomnia-SUD mechanistic pathways are in the direction of substance effects on sleep, although some have proposed that the frequent use of alcohol, marijuana, or sedating medications as sleep aids can lead to the development of SUDs [58, 59]. Other possible mechanisms are related to how chronic sleep loss that occurs with insomnia disorder may alter executive function in ways that promote risk-taking, increase impulsivity, and/or reduce inhibition, all of which could contribute to the development of SUDs. Finally, in the absence of further evidence, it is also quite feasible that although some shared pathway(s) between insomnia and SUDs may exist, the relationship is bidirectional and not necessarily causal.
Insomnia and Suicide
There are now two meta-analyses that support a relationship between sleep disturbance and suicidal outcomes including suicidal ideation, non-fatal suicide attempts, and suicide [60, 61]. In the 2012 meta-analysis, although the majority of studies identified were cross-sectional and/or focused on suicidal ideation as the outcome, several prospective studies supported the relationship between insomnia and suicide attempts and suicide [61]. The second meta-analysis focused exclusively on studies of comorbid insomnia with similar results [60]. In addition, several sleep-suicide reviews have been published since these meta-analyses [62,63,64], which identified a few additional studies supporting a sleep-suicide link. Among them was a large psychological autopsy of suicide decedents (N = 388) compared to a control cohort (N = 416) that found insomnia to be an independent risk factor for suicide [65].
We, however, identified only two new published studies fully meeting our selection criteria [27, 28•]. A study of 252 past and current military service members who endorsed recent suicidal ideation or a lifetime suicide attempt and were re-assessed 12 months later [27]. Here, insomnia, and not depression, was directly predictive of suicidal behaviors at the 12-month follow-up, whereas insomnia’s relationship to suicidal ideation was mediated by cognitive/affective depression. In a longitudinal case-control cohort study, 20 suicide decedents were identified at a 10-year follow-up and matched to 400 control subjects from a large population-based community sample [28•]. Baseline insomnia (termed sleep quality in the publication but based on five items consistent with insomnia disorder) was associated with increased risk for suicide while controlling for depressive symptoms (AOR = 1.30; [1.04–1.63]).
Although, these two new studies (and others identified in recent reviews that did not fully meet our inclusion criteria) do not sizably expand the insomnia-suicide literature, they do continue to support a prospective association between insomnia and the development of suicidal thoughts and behaviors. Studies such as these that control for depressive symptoms or mood disorder diagnoses actually strengthen the literature as a good deal of early work linking sleep and suicide did not control for depression.
Finally, the mechanistic pathways by which insomnia confers risk for subsequent suicide are far from established, though several possibilities exist [66,67,68]. Our own contention is that insomnia and a suicide trajectory may have both a number of shared pathways and some direct insomnia-suicide pathways. In this regard, we suggest that such linkages include those that have been proposed to undergird the insomnia-depression relationship [43]. We proffer simply that neurobiologic and cognitive-behavioral sequelae of insomnia contribute to additional vulnerability for suicide. There is some indication, for instance, that the psychobiologic dysregulation that occurs in insomnia [69] may distinguish suicide attempters from other depressed patients [70, 71]. In addition, as suggested with respect to insomnia and the development of depression, direct consequences of insomnia may diminish coping capacity giving rise to increased disinhibition and poor reasoning that creates vulnerability for suicidal thoughts and behaviors. Impulsivity and emotional dysregulation have also been proposed as one pathway from insomnia to suicide by others [72]. At perhaps the most direct level, being awake at night for extended periods increases the time available to contemplate suicide when others are not awake and when changing distressing thoughts is difficult [73]. These propositions highlight how the addition of insomnia to a co-occurring condition and/or to significant life stressors can further predispose individuals to thoughts of suicide and diminish their capacity to refrain from suicidal behaviors.
Conclusion
In the current systematic review of recently published longitudinal studies, 16 studies were identified that addressed whether insomnia was prospectively associated with a subsequent new onset mental illness. As some studies had more than one mental illness outcome, 23 separate analyses between insomnia and a mental health condition were reviewed. Overall, 15 of 23 comparisons supported a prospective relationship of insomnia to new onset psychiatric illness, two did not support the relationship, and six had mixed results. In sum, recent findings indicate that insomnia is a prospective risk factor for psychiatric illness. The evidence continues to be strongest with respect to the development of depression with accumulating evidence for the a role of insomnia in the development of anxiety disorders, bipolar disorder, and suicide. The limited data with respect to SUDs was mixed, and there were no identified studies with PTSD as an outcome. In general, the small number of studies conducted in child or adolescent samples were more mixed and less robust than findings from studies conducted in adult samples.
If insomnia heralds the onset of mental illness, one must next ask what the potential mechanisms underlying the relationship may be. We have reviewed putative pathways for individual conditions, although it is also useful to think of broad diagnostic-neutral pathways that may exist. Indeed, Harvey has previously proposed taking a transdiagnostic approach to the contribution of sleep disturbance to psychiatric conditions that focused on shared neurobiological substrates [33]. In addition to these, several other pathways exist through which insomnia may precipitate the onset of mental illness. First, at the most basic level, the general psychosocial distress associated with insomnia may serve as the stressor that foments pre-existing vulnerabilities for illness in accord with the diathesis stress model [74]. Second, insomnia has been associated with impaired executive functioning [75] which theoretically contributes to a reduced ability to utilize effective coping strategies and filter negative cognitions. Third, insomnia, and sleep disturbances in general, often result in excessive daytime fatigue and sleepiness, which in turn may decrease one’s engagement in pleasurable activities, social relationships, and associated coping strategies [76]. Fourth, insomnia shares some neurobiological underpinnings with disorders to which it may be a precursor. Last, some cases of insomnia may be prodromal in nature, with impending dysfunction first appearing in the form of sleep disturbance [77].
There are a number of limitations of this review. It focused only on recent additions to the literature and was not a meta-analysis. We did not rate the quality of the studies. We also did not limit the studies by sample size or by the length of the longitudinal period, leaving these study characteristics free to vary. We also chose to accept a liberal definition of insomnia, which means that the samples in some studies may not have met current diagnostic definitions of insomnia disorder. On the other hand, one shortcoming of the study was that we were conservative in focusing only on new onset mental illness, thus precluding a review of how insomnia may contribute to recurrence or relapse in psychiatric conditions. It is also worth noting that the review did not focus on sleep disturbance more broadly or other sleep disorders (e.g., nightmares, obstructive sleep apnea), which are also associated with the onset of some psychiatric conditions.
The clinical implications of this review are not unlike pronouncements that have been made by many others, but bear repeating. The assessment of sleep in general, and insomnia in particular, should be an integral part of a comprehensive assessment and screening strategy by mental health and primary care providers. Identification of insomnia should be followed quickly with direct treatment according to most recently available practice guidelines (i.e., CBT for insomnia as the first-line treatment, with pharmacotherapy as a second-line treatment following a shared decision-making process [78]). Finally, given that insomnia can be a prospective risk factor in the development of mental illness, treatment of insomnia should be considered as both treatment of a serious condition and as preventive mental health care.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Matteson-Rusby SE, Pigeon WR, Gehrman P, Perlis ML. Why treat insomnia? Prim Care Companion J Clin Psychiatry. 2010;12:e1–9.
Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA. 1989;262:1479–84.
Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry. 1996;39:411–8.
Regier DA, Myers JK, Kramer M, Robins LN, Blazer DG, Hough RL, et al. The NIMH epidemiologic catchment area program. Historical context, major objectives, and study population characteristics. Arch Gen Psychiatry. 1984;41:934–41.
Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 2011;135:10–9.
NIH. State of the science conference statement on manifestations and management of chronic insomnia in adults statement. J Clin Sleep Med. 2005;1:412–21.
Geiger-Brown JM, Rogers VE, Liu W, Ludeman EM, Downton KD, Diaz-Abad M. Cognitive behavioral therapy in persons with comorbid insomnia: a meta-analysis. Sleep Med Rev. 2015;23:54–67. doi:10.1016/j.smrv.2014.11.007.
Smith MT, Huang MI, Manber R. Cognitive behavior therapy for chronic insomnia occurring within the context of medical and psychiatric disorders. Clin Psychol Rev. 2005;25:559–92.
Wu JQ, Appleman ER, Salazar RD, Ong JC. Cognitive behavioral therapy for insomnia comorbid with psychiatric and medical conditions: a meta-analysis. JAMA Intern Med. 2015;175:1461–72. doi:10.1001/jamainternmed.2015.3006.
McClintock SM, Husain MM, Wisniewski SR, Nierenberg AA, Stewart JW, Trivedi MH, et al. Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication. J Clin Psychopharmacol. 2011;31:180–6.
Pigeon WR, Hegel M, Unutzer J, Fan MY, Sateia MJ, Lyness JM, et al. Is insomnia a perpetuating factor for late-life depression in the IMPACT cohort? Sleep. 2008;31:481–8.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. doi:10.1371/journal.pmed.1000097.
Alvaro PK, Roberts RM, Harris JK, Bruni O. The direction of the relationship between symptoms of insomnia and psychiatric disorders in adolescents. J Affect Disord, Doi. 2017:167–74. doi:10.1016/j.jad.2016.08.032.
Armstrong JM, Ruttle PL, Klein MH, Essex MJ, Benca RM. Associations of child insomnia, sleep movement, and their persistence with mental health symptoms in childhood and adolescence. Sleep. 2014;37:901–9. doi:10.5665/sleep.3656.
• Chung KH, Li CY, Kuo SY, Sithole T, Liu WW, Chung MH. Risk of psychiatric disorders in patients with chronic insomnia and sedative-hypnotic prescription: a nationwide population-based follow-up study. J Clin Sleep Med. 2015;11:543–51. doi:10.5664/jcsm.4700. This study large study of over 30,000 individuals utilize dignostic coding date to assess the prospective risk of insomnia (with and without the use of ypnotic medications) on several mental health conditions including anxiety disorder, bipolar disorder, depressive disorders, and substance use disorders in adjusted models.
Kang HJ, Bae KY, Kim SW, Shin IS, Yoon JS, Kim JM. Anxiety symptoms in Korean elderly individuals: a two-year longitudinal community study. Int Psychogeriatr. 2016;28:423–33. doi:10.1017/S1041610215001301.
Vedaa O, Krossbakken E, Grimsrud ID, Bjorvatn B, Sivertsen B, Mageroy N, et al. Prospective study of predictors and consequences of insomnia: personality, lifestyle, mental health, and work-related stressors. Sleep Med. 2016;20:51–8. doi:10.1016/j.sleep.2015.12.002.
• Ritter PS, Hofler M, Wittchen HU, Lieb R, Bauer M, Pfennig A, et al. Disturbed sleep as risk factor for the subsequent onset of bipolar disorder—data from a 10-year prospective-longitudinal study among adolescents and young adults. J Psychiatr Res. 2015;68:76–82. doi:10.1016/j.jpsychires.2015.06.005. This epidemiologic study followed participants for up to 10 years and is one of the few to have evaluated the prospective risk of insomnia on subsequent incidence of both bipolar disorder and major depressive disorder.
Dorheim SK, Bjorvatn B, Eberhard-Gran M. Can insomnia in pregnancy predict postpartum depression? A longitudinal, population-based study. PLoS One. 2014;9:e94674. doi:10.1371/journal.pone.0094674.
Drake CL, Pillai V, Roth T. Stress and sleep reactivity: a prospective investigation of the stress-diathesis model of insomnia. Sleep. 2014;37:–304. doi:10.5665/sleep.3916.
Ellis JG, Perlis ML, Bastien CH, Gardani M, Espie CA. The natural history of insomnia: acute insomnia and first-onset depression. Sleep. 2014;37:97–106. doi:10.5665/sleep.3316.
Fernandez-Mendoza J, Shea S, Vgontzas AN, Calhoun SL, Liao D, Bixler EO. Insomnia and incident depression: role of objective sleep duration and natural history. J Sleep Res. 2015;24:390–8. doi:10.1111/jsr.12285.
Hayley AC, Skogen JC, Sivertsen B, Wold B, Berk M, Pasco JA, et al. Symptoms of depression and difficulty initiating sleep from early adolescence to early adulthood: a longitudinal study. Sleep. 2015;38:1599–606. doi:10.5665/sleep.5056.
• Hom MA, Lim IC, Stanley IH, Chiurliza B, Podlogar MC, Michaels MS, et al. Insomnia brings soldiers into mental health treatment, predicts treatment engagement, and outperforms other suicide-related symptoms as a predictor of major depressive episodes. J Psychiatr Res. 2016;79:108–15. doi:10.1016/j.jpsychires.2016.05.008. This study measured the presence and severity of insomnia among 2596 army soldiers at a baseline evaluation in order measure the prospective risk of insomnia on incident depression over the ensuing 18 months.
Hasler BP, Martin CS, Wood DS, Rosario B, Clark DB. A longitudinal study of insomnia and other sleep complaints in adolescents with and without alcohol use disorders. Alcohol Clin Exp Res. 2014;38:2225–33. doi:10.1111/acer.12474.
Wong MM, Robertson GC, Dyson RB. Prospective relationship between poor sleep and substance-related problems in a national sample of adolescents. Alcohol Clin Exp Res. 2015;39:355–62. doi:10.1111/acer.12618.
Allan NP, Conner KR, Pigeon WR, Gros DF, Salami TK, Stecker T. Insomnia and suicidal ideation and behaviors in former and current U.S. service members: does depression mediate the relations? Psychiatry Res. 2017;252:296–302. doi:10.1016/j.psychres.2017.03.009.
• Bernert RA, Turvey CL, Conwell Y, Joiner TE Jr. Association of poor subjective sleep quality with risk for death by suicide during a 10-year period: a longitudinal, population-based study of late life. JAMA Psychiatry. 2014;71:1129–37. doi:10.1001/jamapsychiatry.2014.1126. This cohort study utilized data from an older adult longitudinal study spanning 10 years to compare 20 suicide decedents to 400 matched controls in order to assess the risk posed by insomnia while controlling for several factors including depression
Pigeon WR, Cribbet MR. The pathophysiology of insomnia: from models to molecules (and back). Curr Opin Pulm Med. 2012;18:546–53.
Bonnet MH, Arand DL. Hyperarousal and insomnia: state of the science. Sleep Med Rev. 2010;14:9–15. doi:10.1016/j.smrv.2009.05.002.
Bonnet MH, Arand DL. Caffeine use as a model of acute and chronic insomnia. Sleep. 1992;15:526–36.
Harvey AG. Sleep and circadian functioning: critical mechanisms in the mood disorders? Annu Rev Clin Psychol. 2011;7:297–319. doi:10.1146/annurev-clinpsy-032210-104550.
Harvey AG, Murray G, Chandler RA, Soehner A. Sleep disturbance as transdiagnostic: consideration of neurobiological mechanisms. Clin Psychol Rev. 2011;31:225–35. doi:10.1016/j.cpr.2010.04.003.
Belleville G, Cousineau H, Levrier K, St-Pierre-Delorme ME. Meta-analytic review of the impact of cognitive-behavior therapy for insomnia on concomitant anxiety. Clin Psychol Rev. 2011;31:638–52. doi:10.1016/j.cpr.2011.02.004.
Belleville G, Ivers H, Belanger L, Blais FC, Morin CM. Sequential treatment of comorbid insomnia and generalized anxiety disorder. J Clin Psychol. 2016;72:880–96. doi:10.1002/jclp.22300.
Harvey AG, Schmidt DA, Scarna A, Semler CN, Goodwin GM. Sleep-related functioning in euthymic patients with bipolar disorder, patients with insomnia, and subjects without sleep problems. Am J Psychiatry. 2005;162:50–7. doi:10.1176/appi.ajp.162.1.50.
Eidelman P, Talbot LS, Gruber J, Harvey AG. Sleep, illness course, and concurrent symptoms in inter-episode bipolar disorder. J Behav Ther Exp Psychiatry. 2010;41:145–9. doi:10.1016/j.jbtep.2009.11.007.
Gruber J, Miklowitz DJ, Harvey AG, Frank E, Kupfer D, Thase ME, et al. Sleep matters: sleep functioning and course of illness in bipolar disorder. J Affect Disord. 2011;134:416–20. doi:10.1016/j.jad.2011.05.016.
Jackson A, Cavanagh J, Scott J. A systematic review of manic and depressive prodromes. J Affect Disord. 2003;74:209–17.
Harvey AG, Soehner AM, Kaplan KA, Hein K, Lee J, Kanady J, et al. Treating insomnia improves mood state, sleep, and functioning in bipolar disorder: a pilot randomized controlled trial. J Consult Clin Psychol. 2015;83:564–77. doi:10.1037/a0038655.
Christensen H, Batterham PJ, Gosling JA, Ritterband LM, Griffiths KM, Thorndike FP, et al. Effectiveness of an online insomnia program (SHUTi) for prevention of depressive episodes (the GoodNight study): a randomised controlled trial. Lancet Psychiatry. 2016;3:333–41. doi:10.1016/S2215-0366(15)00536-2.
Manber R, Edinger JD, Gress JL, San Pedro-Salcedo MG, Kuo TF, Kalista T. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep. 2008;31:489–95.
Pigeon WR, Perlis ML. Insomnia and depression: birds of a feather? International Journal of Sleep Disorders. 2007;1:82–91.
Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9:46–56.
Irwin M. Effects of sleep and sleep loss on immunity and cytokines. Brain Behav Immun. 2002;16:503–12.
Mcewen BS. Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol. 2008;583:174–85.
Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65:732–41.
Ross RJ, Ball WA, Sullivan KA, Caroff SN. Sleep disturbance as the hallmark of posttraumatic stress disorder. Am J Psychiatry. 1989;146:697–707.
Pigeon WR, Gallegos AM. Posttraumatic stress disorder and sleep. Sleep Med Clin. 2015;10:41–8. doi:10.1016/j.jsmc.2014.11.010.
Brownlow JA, McLean CP, Gehrman PR, Harb GC, Ross RJ, Foa EB. Influence of sleep disturbance on global functioning after posttraumatic stress disorder treatment. J Trauma Stress. 2016;29:515–21. doi:10.1002/jts.22139.
Garthus-Niegel S, Ayers S, von ST TL, Eberhard-Gran M. Maintaining factors of posttraumatic stress symptoms following childbirth: a population-based, two-year follow-up study. J Affect Disord. 2015;172:146–52. doi:10.1016/j.jad.2014.10.003.
Germain A. Sleep disturbances as the hallmark of PTSD: where are we now? Am J Psychiatry. 2013;170:372–82.
Ho FY, Chung KF, Yeung WF, Ng TH, Kwan KS, Yung KP, Cheng SK. Self-help cognitive-behavioral therapy for insomnia: a meta-analysis of randomized controlled trials. Sleep Med Rev 2015;19:17–28. Doi:10.1016/j.smrv.2014.06.010.
Wallen GR, Brooks AT, Whiting B, Clark R, Krumlauf MC, Yang L, et al. The prevalence of sleep disturbance in alcoholics admitted for treatment: a target for chronic disease management. Fam Community Health. 2014;37:288–97. doi:10.1097/FCH.0000000000000040.
Wong MM, Brower KJ, Fitzgerald HE, Zucker RA. Sleep problems in early childhood and early onset of alcohol and other drug use in adolescence. Alcohol Clin Exp Res. 2004;28:578–87.
Dolsen MR, Harvey AG. Life-time history of insomnia and hypersomnia symptoms as correlates of alcohol, cocaine and heroin use and relapse among adults seeking substance use treatment in the United States from 1991 to 1994. Addiction. 2017; doi:10.1111/add.13772.
Wong MM, Brower KJ. The prospective relationship between sleep problems and suicidal behavior in the National Longitudinal Study of adolescent health. J Psychiatr Res. 2012;46:953–9. doi:10.1016/j.jpsychires.2012.04.008.
Brower KJ. Alcohol's effects on sleep in alcoholics. Alcohol Res Health. 2001;25:110–25.
Stein MD, Friedmann PD. Disturbed sleep and its relationship to alcohol use. Subst Abus. 2005;26:1–13.
Malik S, Kanwar A, Sim LA, Prokop LJ, Wang Z, Benkhadra K, et al. The association between sleep disturbances and suicidal behaviors in patients with psychiatric diagnoses: a systematic review and meta-analysis. Syst Rev. 2014;3:2046–53. doi:10.1186/2046-4053-3-18.
Pigeon WR, Pinquart M, Conner K. Meta-analysis of sleep disturbance and suicidal thoughts and behaviors. J Clin Psychiatry. 2012;73:1160–7.
Bernert RA, Kim JS, Iwata NG, Perlis ML. Sleep disturbances as an evidence-based suicide risk factor. Curr Psychiatry Rep. 2015;17:554. doi:10.1007/s11920-015-0554-4.
Bishop TM, Simons KV, King DA, Pigeon WR. Sleep and suicide in older adults: an opportunity for intervention. Clin Ther. 2016;38:2332–9. doi:10.1016/j.clinthera.2016.09.015.
Pigeon WR, Bishop TM, Titus CE. The relationship of sleep disturbance to suicidal ideation, suicide attempts and suicide among adults: a systematic review. Psychiatr Ann. 2016;46:177–86.
Sun L, Zhang J, Liu X. Insomnia symptom, mental disorder and suicide: a case-control study in chinese rural youths. Sleep Biol Rhythms. 2015;13:181–8. doi:10.1111/sbr.12105.
Nadorff MR, Anestis MD, Nazem S, Claire HH, Samuel WE. Sleep disorders and the interpersonal-psychological theory of suicide: independent pathways to suicidality? J Affect Disord. 2014;15:505–12. doi:10.1016/j.jad.2013.10.011.
McCall WV, Black CG. The link between suicide and insomnia: theoretical mechanisms. Curr Psychiatry Rep. 2013;15:389. doi:10.1007/s11920-013-0389-9.
Woznica AA, Carney CE, Kuo JR, Moss TG. The insomnia and suicide link: toward an enhanced understanding of this relationship. Sleep Med Rev. 2015;22:37–46. doi:10.1016/j.smrv.2014.10.004.
Burgos I, Richter L, Klein T, Feibich B, Feige B, Lieb K, et al. Increased nocturnal interleukin-6 excetion in patients with primary insomnia: a pilot study. Brain Behav Immun. 2006;20:246–53.
Janelidze S, Mattei D, Westrin A, Traskman-Bendz L, Brundin L. Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain Behavior and Immunity. 2011;25:335–9.
Kim YK, Lee SW, Kim SH, Shim SH, Han SW, Choi SH, et al. Differences in cytokines between non-suicidal patients and suicidal patients in major depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2008;32:356–61.
Winsper C, Tang NK. Linkages between insomnia and suicidality: prospective associations, high-risk subgroups and possible psychological mechanisms. Int Rev Psychiatry. 2014;26:189–204. doi:10.3109/09540261.2014.881330.
Perlis ML, Grandner MA, Chakravorty S, Bernert RA, Brown GK, Thase ME. Suicide and sleep: is it a bad thing to be awake when reason sleeps? Sleep Med Rev. 2015;29:101–7. doi:10.1016/j.smrv.2015.10.003.
Zuckerman M. Vulnerability to psychopathology: a biosocial model. Washington, DC: American Psychological Association; 1999.
Fortier-Brochu E, Beaulieu-Bonneau S, Ivers H, Morin CM. Insomnia and daytime cognitive performance: a meta-analysis. Sleep Med Rev. 2012;16:83–94. doi:10.1016/j.smrv.2011.03.008.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Arlington, VA: American Psychiatric Association; 2013.
Perlis ML, Giles DE, Buysse DJ, Tu X, Kupfer DJ. Self-reported sleep disturbance as a prodromal symptom in recurrent depression. J Affect Disord. 1997;42:209–12.
Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165:123–33. doi:10.7326/M15-2175.
Acknowledgements
This work was supported by the VISN 2 Center of Excellence for Suicide Prevention at the Canandaigua VAMC. Dr. Bishop is supported, in part, by the VA Advanced Fellowship Program in Mental Health Illness Research and Treatment. The authors’ views or opinions do not necessarily represent those of the Department of Veterans Affairs, the National Institutes of Health, or the US Government.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Wilfred R. Pigeon reports personal fees from Merck.
Todd M. Bishop and Kelsey M. Krueger each declare no potential conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Sleep Disorders
Rights and permissions
About this article
Cite this article
Pigeon, W.R., Bishop, T.M. & Krueger, K.M. Insomnia as a Precipitating Factor in New Onset Mental Illness: a Systematic Review of Recent Findings. Curr Psychiatry Rep 19, 44 (2017). https://doi.org/10.1007/s11920-017-0802-x
Published:
DOI: https://doi.org/10.1007/s11920-017-0802-x